Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
Abstract
N/A
J Clin Med Res. 2020;12(5):320-322
doi: https://doi.org/10.14740/jocmr4161
User
|
MOST READ |
(For the last 6-month published articles)
Article Tools
Email this article (Login required)
Email this article (Login required) |
INDEXED IN |
|
|
|
|
|
QUICK LINKS |
|
|
|
|
|
|
Editorial Board |
|
|
|
|
|
|
|
|
|
|
|
Conflict of Interest |
|
|
|
|
|
|
|
|
|
|
ARTICLE STATISTICS |
|
Submission to First Decision |
|
23 Days |
|
Acceptance Rate |
|
26% |
|
Acceptance to Publication |
|
19 Days |
|
*Average article statistics from the last 12 months data |